Karin Shanahan is the EVP of Global Product Development and Supply at Bristol Myers Squibb. She oversees worldwide product development, manufacturing, and supply for Bristol Myers Squibb as executive vice president of Global Product Development & Supply (GPS). GPS develops and produces active ingredients and drug products and delivers the company’s medicines globally. The GPS team achieves this mission through a relentless focus on innovation, quality, safety, and agility. She began her career in the pharmaceutical industry at Bristol Myers Squibb in corporate procurement, global supply chain, and global quality. She then moved into manufacturing operations, leading two manufacturing sites in Billerica, MA, and Latina, Italy. After almost 14 years with Bristol Myers Squibb, she joined Becton-Dickinson as a leader of global operations, followed by Catalent Pharmaceuticals, where she led global Biologics operations. In 2013, she joined Teva Pharmaceuticals as SVP and Chief Operating Officer of Global Operations, where she led Global Manufacturing Science & Technology (MS&T) and Network Strategy and a network of 25 sites across Europe and the Americas. Most recently, she served as SVP of Global Biologics & Sterile Operations at Merck. She earned a bachelor’s degree in political science and international relations from Rutgers University and a master’s degree in jurisprudence (MSJ), pharmaceutical and device law, from Seton Hall Law School.